Levemir® FlexPen® is Replacing the Levemir® FlexTouch®
Novo Nordisk® discontinued manufacturing the Levemir® FlexTouch® in early February 2023. The FlexTouch® will be distributed until stock is depleted and is being replaced with the FlexPen®. Please see the charts below for changes between the FlexTouch® and the FlexPen®.
Levemir® FlexTouch® | New! Levemir® FlexPen® | |
Changes | ||
NDC | 00169-6438-10 | 00169-6432-10 |
Pen Needle | NovoFine® or NovoTwist® | NovoFine® or NovoFine® Plus |
Max # of units per single injection | Up to 80 units | Up to 60 units |
Remains the Same | ||
Type of Insulin | Insulin detemir | Insulin detemir |
Manufactured | 3 mL single patient use prefilled pen | 3 mL single patient use prefilled pen |
Unbreakable package size | 5 x 3 mL pens | 5 x 3 mL pens |
How units are dialed | Dialed in 1-unit increments | Dialed in 1-unit increments |
AWP | $554.65 | $554.65 |
# of units needed to prime each pen prior to use | 2 units | 2 units |
PAAS Tips:
- Due to the different features and functions on how to use
- Review the new instructions for the Levemir FlexPen®
- Get an updated prescription to minimize disruption to patient care
Latest posts by Jennifer Ottman, CPhT (see all)
- New Tool on PAAS Portal – Exceeding Days’ Supply Plan Limits for Unbreakable Packages - December 1, 2024
- Understanding Biologic Substitutions – New Tool Available! - November 12, 2024
- FDA Proposed Guidance for Biosimilar Updates - October 23, 2024